BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
31 results:

  • 1. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation.
    Koo J; Ziady AG; Reynaud D; Abdullah S; Luebbering N; Kahn S; Langenberg L; Strecker L; Lake K; Dandoy CE; Lane A; Myers KC; Sabulski A; Good S; Nalapareddy K; Solomon M; Siefert ME; Skala E; Jodele S; Davies SM
    Transplant Cell Ther; 2023 Nov; 29(11):704.e1-704.e8. PubMed ID: 37625594
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience.
    Zamarud A; Park DJ; Dadey DYA; Yoo KH; Marianayagam NJ; Yener U; Szalkowski GA; Pollom E; Soltys S; Chang SD; Meola A
    Neurosurg Focus; 2023 Aug; 55(2):E7. PubMed ID: 37527671
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prostate cancer: Under-representation of African American Men in Research Studies Used in the Latest NCCN Guidelines.
    Lubarsky R; Ambinder D; Barnett J; Choudhury M; Saji A; Fishman AI; Fullerton S; Phillips JL
    Urology; 2023 Oct; 180():28-34. PubMed ID: 37479145
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.
    Al-Hendy A; Lukes AS; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
    J Comp Eff Res; 2023 Aug; 12(8):e230069. PubMed ID: 37477173
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantation.
    Wu L; Wu Y; Shi J; Lai X; Zhao Y; Liu L; Yu J; Yang L; Zhu P; Zheng W; Hu Y; Wu W; Zhu Y; Cai Z; Huang H; Luo Y
    Br J Haematol; 2023 Aug; 202(3):608-622. PubMed ID: 37306071
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
    Sweeney CJ; Martin AJ; Stockler MR; Begbie S; Cheung L; Chi KN; Chowdhury S; Frydenberg M; Horvath LG; Joshua AM; Lawrence NJ; Marx G; McCaffrey J; McDermott R; McJannett M; North SA; Parnis F; Parulekar W; Pook DW; Reaume MN; Sandhu SK; Tan A; Tan TH; Thomson A; Vera-Badillo F; Williams SG; Winter D; Yip S; Zhang AY; Zielinski RR; Davis ID;
    Lancet Oncol; 2023 Apr; 24(4):323-334. PubMed ID: 36990608
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy.
    Hara H; Kawamoto T; Fukase N; Sawada R; Fujiwara S; Yahiro S; Miyamoto T; Terakawa T; Mifune Y; Hoshino Y; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
    Eur J Surg Oncol; 2023 May; 49(5):928-933. PubMed ID: 36463006
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
    Obstet Gynecol; 2022 Dec; 140(6):920-930. PubMed ID: 36357960
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic Review.
    Ward R; Jones HM; Witt D; Boop F; Bouffet E; Rodriguez-Galindo C; Qaddoumi I; Moreira DC
    JCO Glob Oncol; 2022 Oct; 8():e2200199. PubMed ID: 36198134
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Anchor and Krackow-"8" Suture for the Fixation of Distal Pole Fractures of the Patella: Comparison to Kirschner Wire.
    Xie J; Fu Y; Li J; Yu H; Zhang Y; Jing J
    Orthop Surg; 2022 Feb; 14(2):374-382. PubMed ID: 34964263
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Current research status of cytomegalovirus infection after hematopoietic stem cell transplantation: a bibliometric analysis.
    Chen P; Du Z; Qiu S; Wang H; Zhang J; Liu D
    Ann Palliat Med; 2021 Sep; 10(9):9614-9626. PubMed ID: 34628887
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 Probody.
    Kist de Ruijter L; Hooiveld-Noeken JS; Giesen D; Lub-de Hooge MN; Kok IC; Brouwers AH; Elias SG; Nguyen MTL; Lu H; Gietema JA; Jalving M; de Groot DJA; Vasiljeva O; de Vries EGE
    Clin Cancer Res; 2021 Oct; 27(19):5325-5333. PubMed ID: 34253583
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.
    Shijie L; Zhen P; Kang Q; Hua G; Qingcheng Y; Dongdong C
    Clin Transl Med; 2021 Jun; 11(6):e377. PubMed ID: 34185412
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcomes of adolescents and young adults treated for brain and skull base tumors with pencil beam scanning proton therapy.
    Lim PS; Tran S; Kroeze SGC; Pica A; Hrbacek J; Bachtiary B; Walser M; Leiser D; Lomax AJ; Weber DC
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28664. PubMed ID: 32881313
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparative study of surgical orchidectomy and medical castration in treatment efficacy, adverse effects and cost based on a large prospective metastatic prostate cancer registry.
    Tan YG; Poon RJ; Pang LJ; Villanueva A; Huang HH; Chen K; Ng TK; Tay KJ; Ho HS; Yuen JS
    Urol Oncol; 2020 Aug; 38(8):682.e1-682.e9. PubMed ID: 32475745
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial bone and Soft Tissue Sarcomas.
    Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
    Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
    Beelen DW; Trenschel R; Stelljes M; Groth C; Masszi T; Reményi P; Wagner-Drouet EM; Hauptrock B; Dreger P; Luft T; Bethge W; Vogel W; Ciceri F; Peccatori J; Stölzel F; Schetelig J; Junghanß C; Grosse-Thie C; Michallet M; Labussiere-Wallet H; Schaefer-Eckart K; Dressler S; Grigoleit GU; Mielke S; Scheid C; Holtick U; Patriarca F; Medeot M; Rambaldi A; Micò MC; Niederwieser D; Franke GN; Hilgendorf I; Winkelmann NR; Russo D; Socié G; Peffault de Latour R; Holler E; Wolff D; Glass B; Casper J; Wulf G; Menzel H; Basara N; Bieniaszewska M; Stuhler G; Verbeek M; Grass S; Iori AP; Finke J; Benedetti F; Pichlmeier U; Hemmelmann C; Tribanek M; Klein A; Mylius HA; Baumgart J; Dzierzak-Mietla M; Markiewicz M
    Lancet Haematol; 2020 Jan; 7(1):e28-e39. PubMed ID: 31606445
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
    Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs LM; Skoda-Smith S; Chandrakasan S; Yu LC; Oshrine BR; Cuvelier GDE; Thakar MS; Chen K; Teira P; Shenoy S; Phelan R; Forbes LR; Chellapandian D; Dávila Saldaña BJ; Shah AJ; Weinacht KG; Joshi A; Boulad F; Quigg TC; Dvorak CC; Grossman D; Torgerson T; Graham P; Prasad V; Knutsen A; Chong H; Miller H; de la Morena MT; DeSantes K; Cowan MJ; Notarangelo LD; Kohn DB; Stenger E; Pai SY; Routes JM; Puck JM; Kapoor N; Pulsipher MA; Malech HL; Parikh S; Kang EM;
    J Clin Immunol; 2019 Oct; 39(7):653-667. PubMed ID: 31376032
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rural patients are at risk for increased stage at presentation and diminished overall survival in osteosarcoma.
    Wendt R; Gao Y; Miller BJ
    Cancer Epidemiol; 2019 Aug; 61():119-123. PubMed ID: 31212223
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial.
    Bracarda S; Bamias A; Casper J; Negrier S; Sella A; Staehler M; Tarazi J; Felici A; Rosbrook B; Jardinaud-Lopez M; Escudier B
    Clin Genitourin Cancer; 2019 Jun; 17(3):e689-e703. PubMed ID: 31072748
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.